Melanoma Research Alliance

July 22, 2022 by


The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity Request for Proposals (RFP) for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA.

The MRA and RTFCCR will jointly support two team awards for clinical trials with the potential to provide substantial impact to melanoma patients. These awards seek to support novel, interventional clinical trials with the goal of making a significant difference to melanoma patients in the short term. Patient engagement must be actively demonstrated throughout the full life cycle of the clinical trial, including planning and dissemination. For more information about how to effectively engage patients in guiding research please watch this video and use this guide.

These awards will support innovative approaches with preliminary data, where funding is required to bring better treatment options forward for evaluation in a clinical trial. We welcome applications from all research groups with a track record in melanoma. Grant applicants should actively involve patients in the protocol design.

Term: Up to five years

Amount: Up to $1,500,000. Co-funding is welcome. If the total cost of the trial exceeds $1,500,000, applicants must include a plan to secure the remainder of the funding to ensure the trial can be completed.

Number of Expected Awards: Up to two awards will be supported.

Key Deadlines:

  • Letters of Intent due 11:59 p.m. Eastern Time, October 5, 2022
  • Estimated LOI decisions: November 18, 2022
  • Invited Full Proposals due 11:59 p.m. Eastern Time, January 18, 2023

How to Apply: Applicants should submit to the RTFCCR-MRA Team Science Award LOI opportunity in Proposal Central.

All application materials are due by 11:59 pm Eastern Time on the date specified. Proposals should be submitted via the proposalCENTRAL on-line application tool:

Filed Under: Funding Opportunities